Abvc Biopharma (ABVC) Tax Rate (2016 - 2026)
Abvc Biopharma's (ABVC) quarterly Tax Rate came in at 21.0% in Q2 2026, up 2202.0% on a YoY basis from 0.91% in Q2 2025, and little changed quarter-over-quarter from 21.0% in Q1 2026.
Powered by 
Analysis
Abvc Biopharma (ABVC) Tax Rate (2016 - 2026) Analysis & Trends
Abvc Biopharma (ABVC) has reported Tax Rate for 11 consecutive years, with 21.0% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Tax Rate rose 2202.0% year-over-year to 21.0%; the trailing twelve-month figure through Jun 2026 stood at 6.9% (up 307.0% YoY), and the FY2025 full-year result was 0.29%, down 235.0% from the prior year.
- Tax Rate steadied at 21.0% in Q2 2026 per ABVC's latest filing, from 21.0% in the prior quarter.
- Across five years, Tax Rate topped out at 21.0% in Q1 2026 and bottomed at 33.39% in Q4 2023.
- Historically, Tax Rate has averaged 0.9% across 5 years, with a median of 0.0% in 2025.
- The sharpest annual moves came in 2025 and 2026: Tax Rate slumped 1060 bps in 2025, then jumped 2202 bps in 2026.
- Over 5 years, Tax Rate stood at 27.21% in 2022, then slipped by 23 bps to 33.39% in 2023, then soared by 100 bps to 0.07% in 2024, then soared by 65 bps to 0.03% in 2025, then surged by 83102 bps to 21.0% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 21.0%, 21.0%, and 0.03% for Q2 2026, Q1 2026, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 14.20% |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -2.36% |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 20.98% |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 15.11% |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | -10.89% |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -1.96% |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 7.49% |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 26.36% |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 1.34% |
| 10 | Abvc Biopharma | 25.56 Mn | 25.56 Mn | - | 21.00% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.00% |
| Mar 31, 2026 | 21.00% |
| Sep 30, 2025 | -0.03% |
| Jun 30, 2025 | -1.02% |
| Mar 31, 2025 | 20.98% |
| Sep 30, 2024 | -0.07% |
| Jun 30, 2024 | 9.57% |
| Dec 31, 2023 | -33.39% |
| Sep 30, 2023 | 0.03% |
| Jun 30, 2023 | -3.66% |
| Dec 31, 2022 | -27.21% |
| Sep 30, 2022 | -0.11% |
| Jun 30, 2022 | 4.06% |
| Mar 31, 2022 | 1.41% |
| Dec 31, 2021 | -17.17% |
| Sep 30, 2021 | 3.86% |
| Jun 30, 2021 | 2.82% |
| Mar 31, 2021 | 4.09% |
| Dec 31, 2020 | 1.71% |
| Sep 30, 2020 | 2.06% |